Skip to main content
logo
Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.900
0.00 (0.00%)
Oct 13, 2026, 1:54 PM CET

Elicera Therapeutics AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
19425359907099
Market Cap Growth
-45.23%332.31%-35.03%29.73%-29.98%-
Enterprise Value
13521828643146
Last Close Price
2.905.091.634.443.424.89

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
24.8423.348.228.0354.32169174.86
PB Ratio
3.4410.852.825.502.121.90
P/TBV Ratio
3.4410.852.825.502.121.90

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
17.3820.123.925.7324.3978418.50

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-1.03-1.06-1.27-1.79-1.34-1.00
Net Debt / EBITDA Ratio
-1.391.571.722.274.00
Asset Turnover
0.160.400.250.290.030
Quick Ratio
17.816.134.012.163.2721.04
Current Ratio
17.816.634.062.193.3921.68
Return on Equity (ROE)
-41.69%-78.89%-86.68%-66.66%-45.72%-42.00%
Return on Assets (ROA)
-22.89%-40.79%-36.55%-27.94%-23.95%-24.36%
Return on Capital Employed (ROCE)
-32.70%-76.80%-81.30%-104.20%-59.00%-25.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-9.29%-6.87%-27.49%-18.18%-27.96%-13.21%
Buyback Yield / Dilution
-28.58%-45.01%-59.89%0.40%-23.97%-32.98%